Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
30
30 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- BMS-986507BL-B01D1, Iza-brenPhase 351 trials
Sichuan Baili Pharmaceutical Co., Ltd. · Non-small Cell Lung Cancer, Solid Tumor, Urothelial Carcinoma
- KarX-ECBMS-986519, Xanomeline Enteric-coatedPhase 39 trials
Bristol Myers Squibb · Alzheimer Disease, Alzheimer's Disease, Irritability Associated With Autism Spectrum Disorder
- BMS-986348CC-92480, mezigdomidePhase 37 trials
Bristol Myers Squibb · Multiple Myeloma, Relapsed or Refractory Multiple Myeloma
- CC-99282BMS-986369, GolcadomidePhase 37 trials
Bristol Myers Squibb · Lymphoma, Follicular, Large B-cell Lymphoma, Non-Hodgkin Lymphoma
- rHuPH20Phase 35 trials
Bristol Myers Squibb · Melanoma, Relapsing-remitting Multiple Sclerosis, Clear Cell Renal Cell Carcinoma
- NavlimetostatBMS-986504, MRTX1719Phase 34 trials
Bristol Myers Squibb · Pancreatic Ductal Adenocarcinoma, Metastatic Non-small Cell Lung Cancer With MTAP Deletion, Solid Tumors
- BMS-986278AdmilparantPhase 33 trials
Bristol Myers Squibb · Pulmonary Fibrosis, Progressive Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis
- CasdatifanAB521Phase 33 trials
Arcus Biosciences, Inc. · Metastatic Clear Cell Renal Cell Carcinoma, Advanced Clear Cell Renal Cell Carcinoma, Advanced Renal Cell Carcinoma (RCC)
- Zola-celBMS-986353, CC-97540Phase 33 trials
Bristol Myers Squibb · Systemic Sclerosis, Lupus Erythematosus, Systemic, Lupus Nephritis
- Arlocabtagene AutoleucelBMS-986393, GPRC5D CAR T cellsPhase 32 trials
Bristol Myers Squibb · Multiple Myeloma, Relapsed or Refractory Multiple Myeloma (RRMM)
- Atigotatug+NivolumabBMS-986489Phase 31 trial
Bristol Myers Squibb · Extensive-Stage Small Cell Lung Cancer
- BMS-986158Phase 22 trials
Bristol Myers Squibb · Myelofibrosis, Multiple Myeloma
- ImzokitugBMS-986340Phase 22 trials
Bristol Myers Squibb · Locally Advanced Non-Small Cell Lung Cancer (NSCLC), Metastatic Non-Small Cell Lung Cancer (NSCLC), Cervical Cancer
- BMS-986012Phase 21 trial
Bristol Myers Squibb · Extensive-stage Small Cell Lung Cancer
- BMS-986213Phase 21 trial
Bristol Myers Squibb · Advanced Solid Tumors
- BMS-986435MYK-224Phase 21 trial
Bristol Myers Squibb · Heart Failure
- BMS-986446Phase 21 trial
Bristol Myers Squibb · Alzheimer Disease, Early Onset
- BMS-986449Phase 21 trial
Bristol Myers Squibb · Advanced Solid Tumors
- BMS-986458Phase 21 trial
Bristol Myers Squibb · Relapsed/Refractory Non-Hodgkin Lymphoma
- BMS-986470Phase 21 trial
Bristol Myers Squibb · Anemia, Sickle Cell, Healthy Volunteers
- BMS-986482Phase 21 trial
Bristol Myers Squibb · Advanced Solid Tumors
- BMS-986490Phase 21 trial
Bristol Myers Squibb · Advanced Solid Tumors
- BMS-986511EvifacotrepPhase 21 trial
Bristol Myers Squibb · Major Depressive Disorder
- BMS-986517Phase 21 trial
Bristol Myers Squibb · Solid Tumours
- BMS-986523Phase 21 trial
Bristol Myers Squibb · Advanced Solid Malignancies, Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC)
- BMS-986525Phase 21 trial
Bristol Myers Squibb · Relapsed/Refractory Small Cell Lung Cancer
- BMS-986528Phase 21 trial
Bristol Myers Squibb · Arthritis, Rheumatoid
- BMS-986548Phase 21 trial
Bristol Myers Squibb · Advanced Solid Malignancies
- LinrodostatBMS-986205Phase 21 trial
Bristol Myers Squibb · Advanced Cancer
- Liso-celPhase 21 trial
Bristol Myers Squibb · Lymphoma
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.